Because a shortage of new antimicrobial agents is a critical issue at present, and with the spread of multidrug-resistant (MDR) pathogens, the use of fosfomycin to treat infections is being revisited as a "last-resort option." This drug offers a particular benefit in that it is more effective against bacteria growing under oxygen-limited conditions, unlike other commonly used antimicrobials, such as fluoroquinolones and aminoglycosides. In this study, we showed that Escherichia coli strains, including enterohemorrhagic E. coli (EHEC), were more susceptible to fosfomycin when grown anaerobically than when grown aerobically, and we investigated how the activity of this drug was enhanced during anaerobic growth of E. coli. Our quantitative PCR analysis and a transport assay showed that E. coli cells grown under anaerobic conditions had higher levels of expression of glpT and uhpT, encoding proteins that transport fosfomycin into cells with their native substrates, i.e., glycerol-3-phosphate and glucose-6-phosphate, and led to increased intracellular accumulation of the drug. Elevation of expression of these genes during anaerobic growth requires FNR, a global transcriptional regulator that is activated under anaerobic conditions. Purified FNR bound to DNA fragments from regions upstream of glpT and uhpT, suggesting that it is an activator of expression of glpT and uhpT during anaerobic growth. We concluded that the increased antibacterial activity of fosfomycin toward E. coli under anaerobic conditions can be attributed to elevated expression of GlpT and UhpT following activation of FNR, leading to increased uptake of the drug.
I
n addition to pathogens acquiring resistance to antimicrobial agents by genetic modifications, a reduction of the antimicrobial activity of drugs associated with environmental changes is a potential risk factor that impairs antimicrobial chemotherapy. Bacteria often encounter oxygen-limited situations during infection of the host. In many cases, the antibacterial activities of drugs, including fluoroquinolones and aminoglycosides, decrease when oxygen is depleted (1) (2) (3) (4) .
Fosfomycin recently regained attention as an antibiotic that could be effective against multidrug-resistant (MDR) pathogens, such as extended-spectrum ␤-lactamase (ESBL) producers, because there is no structural relationship between the drug and other commonly used antimicrobials, including fluoroquinolones, ␤-lactams, and aminoglycosides (5, 6) . Fosfomycin is also used to decrease the risk of development of hemolytic-uremic syndrome (HUS), a fatal infectious disease caused by enterohemorrhagic Escherichia coli (EHEC) O157:H7 (7, 8) . As another great benefit, this drug is more effective under anaerobic conditions (9, 10) . However, the reason for this increased effectiveness is poorly understood.
Fosfomycin is transported via GlpT and UhpT, which are glycerol-3-phosphate and glucose-6-phosphate symporters, respectively, and then inhibits MurA activity, which transfers phosphoenolpyruvate (PEP) to the 3=-hydroxyl group of UDP-N-acetylglucosamine in the initial step of bacterial cell wall biosynthesis (11) (12) (13) . Susceptibility to fosfomycin can be affected by expression of the genes encoding GlpT, UhpT, and MurA. In some E. coli studies, mutations in genes encoding the positive regulators of uhpT expression, UhpA and CyaA, conferred resistance because the mutants had reduced uptake of fosfomycin (14, 15) . Other studies showed that a clinical isolate resistant to fosfomycin produces a MurA variant that results in overexpression of MurA (16) . In addition to these genetic mutations, the expression of glpT and uhpT can be altered reversibly in response to environmental changes. We recently found that CpxAR and TorSRT, which are two-component systems in EHEC, regulate the glpT and uhpT genes (17, 18) . Fosfomycin as well as indole and trimethylamine-N-oxide (TMAO), which are secondary metabolites derived from the gut microbiota, activate these respective systems and repress the glpT and uhpT genes, resulting in increased tolerance to fosfomycin in EHEC. This implies that the CpxAR and TorSRT systems contribute to innate tolerance to fosfomycin in EHEC. We aimed to gain further insight into the molecular mechanism of glpT and uhpT gene expression associated with susceptibility to fosfomycin, as such an insight will help us to establish a strategy that enhances the utility of this drug.
For E. coli strains, including EHEC strains, available oxygen is depleted at enteric sites where they reside or cause infection. When oxygen is depleted, they can alter the expression of subsets of genes, including genes responsible for metabolism, and then switch their respiration from aerobiosis to anaerobiosis to efficiently obtain bioenergy (19) . FNR (fumarate nitrate reduction) and Arc (aerobic respiration control) are the central regulatory systems for altering the gene expression profile to maximize cell growth under anaerobic conditions. The FNR protein is a transcriptional regulator containing an Fe-S cluster, and it serves as a redox sensor and is active during anaerobic growth (20) . The protein contains cysteine clusters in the N-terminal region which are responsible for a conformational change in the protein to its active, DNA-binding form in response to anaerobiosis. The Arc system is a two-component system that is composed of ArcA, the response regulator, and ArcB, the sensor kinase. ArcB is autophosphorylated during the transition from aerobic to microaerobic growth and then transfers the phosphate to ArcA (21) . The phosphorylated ArcA protein represses genes encoding enzymes to operate the tricarboxylic acid (TCA) cycle during aerobic respiration in cells while activating a subset of genes encoding enzymes involved in fermentative metabolism (22) .
In this study, we initially showed that fosfomycin is more active against EHEC grown anaerobically than against that grown aerobically. We provided evidence, using genetic and biochemical approaches, that EHEC cells in anaerobic growth have higher expression levels of both glpT and uhpT and more uptake of fosfomycin, leading to increased susceptibility to this drug. We also found that elevated expression of glpT and uhpT during anaerobic growth required FNR. In addition to EHEC, we showed that other E. coli members are also more susceptible to fosfomycin under anaerobic conditions, for the same reason. These data provide insights into the mechanism of action of fosfomycin toward E. coli under anaerobic conditions.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Unless otherwise indicated, all bacteria were grown in Luria-Bertani (LB) medium. EHEC strains were grown aerobically in glass tubes with shaking at 160 rpm. For anaerobic culture, we grew EHEC in a sealed container with gas generators (AnaeroPack-Anaero; Mitsubishi Gas Chemical Co., Inc., Tokyo, Japan). We also used the nonpathogenic K-12 strain (24), a uropathogenic E. coli (UPEC) strain (25) , and an ESBL-producing E. coli clinical isolate designated GU1193. The ESBL producer was originally isolated from a urinary catheter placed in a hospitalized patient and is highly resistant to cefotaxime, piperacillin, and levofloxacin (MICs of 32, 128, and 16 g/ml, respectively). The cell growth was monitored by measuring the absorbance at 600 nm. For marker selection and maintenance of plasmids, antibiotics were added to the growth medium at the following concentrations: 150 g/ml ampicillin, 15 g/ml chloramphenicol, and 25 g/ml kanamycin.
Cloning and mutant construction. In-frame deletions of uhpT, fnr, and arcA were constructed by sequence overlap extension PCR according to a previously described strategy (26) , using the delta1/delta2 and delta3/ delta4 primer pairs for each gene ( Table 2 ). The upstream flanking DNA included 450 bp of sequence, the first four amino acid codons for uhpT, and the first three amino acid codons for fnr and arcA. The downstream flanking DNA included the last four amino acid codons for uhpT, the last three amino acid codons for fnr, the last two amino acid codons for arcA, the stop codon, and 450 bp of additional DNA. These deletion constructs were ligated into the BamHI-and SalI-digested temperature-sensitive vector pKO3 (26) and introduced into HH-H7-008, the parent strain (23) . We selected sucrose-resistant, chloramphenicol-sensitive colonies at 30°C and confirmed the resulting mutant strains by PCR analysis and DNA sequencing.
To construct the His 6 -D154AFnr expression plasmid pTrc99-6HisD154Afnr, we initially constructed pTrc99-6Hisfnr. The fnr gene was amplified with the primer pair shown in Table 2 . The product was digested with NcoI and BamHI and ligated into the similarly digested pTrc99K plasmid (27) to generate pTrc99-6Hisfnr. The pTrc99-6HisfnrD154A plasmid was constructed by site-directed mutagenesis of pTrc99-6Hisfnr. The mutations were generated by using the primer pairs shown in Table 2 and a QuikChange site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA), with the following modification: we used KOD FX Neo polymerase (Toyobo Co., Ltd., Osaka, Japan) instead of Pfu Turbo DNA polymerase for PCR amplification.
To construct pNNuhpT-P, a lacZ reporter plasmid to measure uhpT promoter activity, we PCR amplified the 300-bp region upstream of the uhpT gene by using the primers uhpT-PF and uhpT-PR and ligated the product into the NotI-and HindIII-digested pNN387 plasmid with promoterless lacZ (28) . All constructs were confirmed by DNA sequencing. Drug susceptibility assays. MIC assays were performed by the standard serial agar dilution method of the Clinical and Laboratory Standards Institute (CLSI) (29) . The MIC was determined as the lowest concentration at which growth was inhibited. To examine bacterial survival rates in fosfomycin-containing broth, a 50-fold dilution of overnight standing culture was inoculated into fresh LB broth, and bacteria were grown to mid-logarithmic phase. One-milliliter portions of cultures were transferred to microcentrifuge tubes containing fosfomycin and incubated at 37°C without shaking for 1 h. For fosfomycin-free controls, separate 1-ml portions of the cultures were incubated in the absence of fosfomycin. Survival rates were determined as the percent CFU of fosfomycin-treated cells compared to fosfomycin-free control cells.
Fosfomycin active transport assays. Assays to test for the accumulation of fosfomycin in bacterial cells were conducted as previously described (17) . Bacteria were grown in 20 ml of LB medium to late logarithmic phase and resuspended in 1 ml of LB medium. This suspension was incubated for 60 min at 37°C in the presence of 2 mg of fosfomycin per ml and then washed three times with hypertonic buffer (10 mM Tris [pH 7.3], 0.5 mM MgCl 2 , and 150 mM NaCl) to remove the antibiotic. Cells were resuspended in 0.5 ml of distilled water and plated on LB agar to determine the number of CFU/ml. The resuspended bacteria were boiled at 100°C for 3 min to release the fosfomycin. After centrifugation, the antibiotic concentration in the supernatant was determined by a disc diffusion assay. In this assay, sterilized assay discs (13 mm; Whatman, Florham Park, NJ) were saturated with 0.1 ml of the supernatant and deposited onto LB agar plates overlaid with a 1:10 dilution of an overnight culture of E. coli MG1655 as a reporter strain (24) . Commercial fosfomycin was used as a standard (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Fosfomycin concentrations in supernatants were quantified by measuring the diameter (in millimeters) of the inhibitory zones on the LB agar culture and are presented in nanograms per 10 7 cells. RNA extraction and quantitative real-time PCR analyses. Bacteria were grown to the mid-logarithmic growth phase (optical density at 600 nm [OD 600 ], ϳ0.4) in LB medium. Total RNA extraction and cDNA synthesis were performed using an SV total RNA isolation system and a GoScript reverse transcription system as described by the manufacturer (Promega Corp., Madison, WI). Real-time PCR mixtures included 2.5 ng cDNA and 200 nM (each) primers in SYBR Select master mix (Applied Biosystems, Foster City, CA) and were run on an ABI Prism 7900HT Fast real-time PCR system. The constitutively expressed rrsA and rpoD genes were used as internal controls. Primers are listed in Table 2 . Amplification plot and melting curve data are available upon request.
Overexpression and purification of D154AFNR. N-terminally histidine-tagged D154AFNR (His 6 -D154AFnr) was expressed in and purified from Escherichia coli Rosetta(DE3) (Novagen/EMD Bioscience, Philadelphia, PA). Bacteria containing the recombinant plasmid were grown at 37°C to an OD 600 of 0.4 in LB medium, 0.5 mM IPTG (isopropyl-␤-Dthiogalactopyranoside) was then added, and culture growth was continued for 3 h. Cells were harvested and stored at Ϫ80°C overnight. The cell pellet was suspended in lysis buffer (20 mM Tris [pH 7.9], 500 mM NaCl, and 10% glycerol) and lysed by sonication. The lysate was centrifuged, and the resulting supernatant was mixed with Ni-nitrilotriacetic acid (Ni-NTA) agarose (Qiagen, Valencia, CA) for 1 h. The agarose was washed Gel shift assays. To assess FNR binding to the glpT and uhpT promoter sequences in gel shift assays, we used 321-bp DNA probes containing the 300-bp regions upstream of the glpT and uhpT start codons, respectively. We also used a 323-bp DNA fragment of the Pseudomonas aeruginosa rhlR gene as a nonspecific control probe. The probe DNA fragments (0.30 pmol) were mixed with purified D154AFNR in a 10-l reaction mixture. After incubation for 20 min at room temperature, samples were separated by electrophoresis on a 5% nondenaturing Tris-glycine-EDTA (10 mM Tris [pH 8.0], 380 mM glycine, and 1 mM EDTA) acrylamide gel in Tris-glycine-EDTA buffer at 4°C. The gel was incubated in 10,000-fold-diluted SYBR green I nucleic acid stain (Lonza, Walkersville, MD), and DNA was visualized under UV light at 300 nm.
Promoter assays. EHEC strains carrying pNN-glpT-P or pNNuhpT-P, the LacZ reporter plasmid, were grown aerobically or anaerobically at 37°C in LB medium. To measure LacZ expression from pNNuhpT-P, we added 25 g/ml of glucose-6-phosphate to the medium, because the promoter activity of the uhpT gene was too low to be detected in the absence of glucose-6-phosphate. ␤-Galactosidase activities from LacZ expression in cell lysates were determined as described by Miller (30) .
RESULTS
Anaerobically grown EHEC cells are more susceptible to fosfomycin. To test the susceptibility of EHEC to fosfomycin under anaerobic conditions, we determined the MICs of fosfomycin by an agar dilution method for the wild-type parent EHEC strain grown aerobically or anaerobically. We found that the MIC for anaerobically grown cells was 8-fold lower than that for aerobically grown cells (MIC of 0.5 g/ml for anaerobically grown cells versus 4 g/ml for aerobically grown cells) ( Table 3) . We also measured survival rates with fosfomycin for anaerobically and aerobically grown EHEC cells after treatment with 1.56 g/ml of fosfomycin as described in Materials and Methods. Under aerobic culture conditions, the number of CFU after incubation in the presence of fosfomycin was 2.14% (Ϯ1.66%) of the number of CFU in the absence of fosfomycin (Fig. 1) . Under anaerobic conditions, the survival rate of EHEC was only 0.016% (Ϯ0.009%) after fosfomycin treatment (Fig. 1) . This is consistent with the results of MIC experiments and indicates that EHEC is more susceptible to fosfomycin when it is grown anaerobically.
Anaerobically grown EHEC has higher transcription levels of glpT and uhpT, which result in increased intracellular accumulation of fosfomycin. In anaerobically grown cells, intracellular accumulation of fosfomycin might be increased, which would lead to a higher level of susceptibility to the drug. To examine if this hypothesis is correct, we compared intracellular levels of fosfomycin between anaerobically and aerobically grown cells by a transport assay as described in Materials and Methods. The level of fosfomycin in anaerobic culture was 12-fold higher than that in aerobic culture (82.3 Ϯ 1.9 ng/10 7 cells for aerobic culture versus 974.2 Ϯ 476.7 ng/10 7 cells for anaerobic culture) (Fig. 2) . We also measured the transcript levels of glpT and uhpT, encoding transporters for fosfomycin uptake, in aerobically and anaerobically grown cells by quantitative PCR (qPCR) analysis. The glpT and uhpT expression levels in anaerobically grown cells were 70-and 13-fold higher, respectively, than those in aerobically grown cells (Fig. 3) . As a control, no significant difference in transcript levels of murA, encoding a target protein for the drug, was observed between these strains.
To confirm that elevated expression of glpT and uhpT in anaerobically grown cells leads to increased susceptibility, we compared the levels of susceptibility to fosfomycin between aerobic and anaerobic cultures for glpT and uhpT gene deletion mutants. These mutants showed less susceptibility than the wild-type par-
FIG 1
Survival rates of wild-type parent strains grown under aerobic or anaerobic conditions after incubation with or without 1.56 g/ml fosfomycin. The survival rates are given as percentages of CFU/ml for strains after incubation with fosfomycin compared to those without fosfomycin. Data plotted are the means for three independent experiments; error bars indicate the standard deviations. ent under both aerobic and anaerobic conditions, suggesting that GlpT-and UhpT-dependent fosfomycin uptake indeed contributes to the growth inhibition. The MICs were as follows: 0.5 g/ml for the parent anaerobic culture, 4 g/ml for the parent aerobic culture, 16 g/ml for the ⌬glpT anaerobic culture, 32 g/ml for the ⌬glpT aerobic culture, 2 g/ml for the ⌬uhpT anaerobic culture, 8 g/ml for the ⌬uhpT aerobic culture, 64 g/ml for the ⌬glpT ⌬uhpT anaerobic culture, and 128 g/ml for the ⌬glpT ⌬uhpT aerobic culture (Table 3) . MICs for these mutants under anaerobic conditions were only 2-fold (for the ⌬glpT and ⌬glpT ⌬uhpT strains) or 4-fold (for the ⌬uhpT strain) lower than those under aerobic conditions, while the decremental degree of the MIC in the wild-type background was 8-fold. These combined results indicate that increased susceptibility to fosfomycin during anaerobic growth in EHEC is partly due to an elevated expression of GlpT and UhpT that leads to increased intracellular accumulation of the drug.
The anaerobic transcriptional activator FNR is responsible for the elevation of glpT and uhpT expression levels under anaerobic conditions. FNR and ArcAB are major proteins that are responsible for induction of genes during anaerobic growth (20, 21) . These proteins can be activated when oxygen is depleted. To examine the involvement of FNR and ArcAB in elevated expression of glpT and uhpT during anaerobic growth, we constructed fnr and arcAB deletion mutants and then determined the MICs of fosfomycin for these mutants when they were grown aerobically and anaerobically. We found that the fnr mutant showed a 4-fold lower susceptibility than that of the wild-type parent during anaerobic growth (MIC of 0.5 g/ml for the wild-type parent versus 2 g/ml for the fnr mutant), but there was no difference in the MIC between these strains during aerobic growth (MIC of 4 g/ml for the wild-type parent and the fnr mutant) ( Table 3) . On the other hand, the deletion of arcA did not affect the MIC of fosfomycin even under anaerobic conditions.
We measured the promoter activities of glpT and uhpT via LacZ expression from the reporter plasmids pNN-glpT-P and pNN-uhpT-P, containing 300-bp regions upstream of the glpT and uhpT transcriptional start sites, respectively, fused to a promoterless lacZ gene. The wild-type parent carrying each reporter plasmid was grown aerobically or anaerobically in LB broth. We added glucose-6-phosphate as an inducer to measure LacZ expression from pNN-uhpT-P so that the basal level of promoter activity would be increased to a detectable level. Consistent with the qPCR results, LacZ expression levels from both pNN-glpT-P and pNN-uhpT-P in the wild-type parent grown under anaerobic conditions were 7.0-to 9.0-fold higher than those under aerobic conditions ( Fig. 4A and B) . However, LacZ expression from pNNglpT-P in the fnr mutant grown under anaerobic conditions was at the same level as that in the wild-type parent and the fnr mutant grown under aerobic conditions (Fig. 4A) . LacZ expression from pNN-uhpT-P in the fnr mutant grown anaerobically was significantly lower than that in the wild-type parent; however, unlike the level from the glpT promoter, the level was still 3-fold higher than that in the wild-type parent and the fnr mutant when these strains were grown aerobically (Fig. 4B) . We also measured LacZ expression from pNN-glpT-P and pNN-uhpT-P in the arcA mutant background. Consistent with the results of MIC determination, LacZ expression in the mutant was elevated when the strain was grown anaerobically as well as in the wild-type parent; thus, the ArcAB system does not contribute to elevations of glpT and uhpT expression during anaerobic growth (Fig. 4A and B) . These observations suggest that elevations of glpT and uhpT expression during anaerobic growth require the fnr gene, but there might be yet another regulatory element for the uhpT gene.
FNR binds to glpT and uhpT upstream regions. To determine if FNR directly activates the expression of glpT and uhpT, we tested the ability of FNR to bind to the regions upstream of their promoters by performing a gel shift assay. The FNR protein remains in an inactive state in the presence of oxygen; therefore, we used the D154A mutant protein for this assay. The D154A mutant is an FNR protein with alanine substituted for aspartate at amino acid residue 154, and it is able to form a dimer which is in an active conformation even in the presence of oxygen and then to bind to the target DNA in the same fashion as that of wild-type FNR (31) . We observed delayed mobilities of glpT and uhpT upstream region DNAs on electrophoresis, but not of rhlR from Pseudomonas aeruginosa (nonspecific control), suggesting that control of glpT and uhpT expression by FNR is direct (Fig. 5) . We also noted that D154AFNR bound to the glpT promoter with a higher affinity than that for the uhpT promoter, because the mobility of the DNA fragment from the glpT upstream region was mostly shifted in the presence of 8 pmol of protein, whereas a significant amount of unshifted uhpT fragment was still observed at the same concentration of protein. These observations agree with the results of promoter assays showing that FNR contributes to the activation of glpT expression to a higher degree than that for uhpT expression.
Non-EHEC members are also more susceptible to fosfomycin under anaerobic conditions. To test whether other E. coli members are also more susceptible to fosfomycin under anaerobic conditions, we compared the MICs of fosfomycin in MG1655 (a nonpathogenic K-12 strain), the non-gastrointestinally infectious UPEC strain CFT073, and the ESBL-producing clinical isolate GU1193 cultured under aerobic and anaerobic conditions. All of them exhibited 8-fold lower MICs during anaerobic culture (Table 4). We also measured the transcript levels of glpT and uhpT by qPCR analysis for these E. coli strains grown aerobically or anaerobically. Similar to the results of the experiment with EHEC, both glpT and uhpT expression levels in anaerobically grown cells were higher than those in aerobically grown cells (Fig. 6A to C) . We note that the degree of elevation of the glpT transcript in MG1655 was relatively lower than those in the other E. coli strains, although the reason for this is unclear (3-fold elevation for MG1655 versus 70-, 80-, and 50-fold elevations for EHEC O157, CFT073, and GU1193, respectively). To compare the sequences of the fnr open reading frame and the regions upstream of the glpT and uhpT genes among these E. coli strains, including the EHEC strain, we determined these sequences for GU1193 because the complete genome sequence for this strain has not been available. Among EHEC O157, MG1655, CFT073, and GU1193, the sequences were Ͼ95% identical. These observations suggest that MG1655, CFT073, and GU1193 are more susceptible to fosfomycin under anaerobic conditions due to elevated expression of GlpT and UhpT via FNR activation in the same fashion as that observed for EHEC.
DISCUSSION
The antibacterial activity of fosfomycin is relatively low compared with those of other commonly used bactericidal drugs under the typical standard laboratory conditions, which include aerobic culture in rich media (29) . However, the activity of fosfomycin increases under anaerobic conditions, whereas those of other bactericidal drugs decrease (1-4, 9, 10). Oxygen-limited situations are very common for bacteria during the infection process, for instance, when they are in an enteric site and growing with other members in a microbial complex as a biofilm. Recently, combination treatment with fosfomycin and other drugs has been proposed to improve antibacterial therapy against pathogens growing in a biofilm (10, 32) . Insights into the mechanism of action of fosfomycin toward bacteria growing under anaerobic conditions, such as understanding how fosfomycin is more effective against anaerobically grown cells, will aid us in establishing a method to enhance the efficacy of fosfomycin treatment. We focused mainly on EHEC here, because available oxygen is strictly limited at the enteric site where it infects the host and fosfomycin is traditionally used for treatment (7, 8) . Our study initially showed that EHEC grown anaerobically is indeed more susceptible to this drug (Table  3 ; Fig. 1 ). We provided direct evidence that cells during anaerobic growth had elevated production of GlpT and UhpT and resulted in increased uptake of the drug (Table 3 ; Fig. 2 to 4) . In addition, although we originally studied EHEC, fosfomycin was also more active against other E. coli members, including the laboratory K-12 strain, UPEC, and an ESBL-producing clinical isolate, under anaerobic conditions, with higher expression levels of GlpT and UhpT, as observed with EHEC (Table 4 ; Fig. 6 ).
The native function of GlpT and UhpT is to transport glycerol-3-phosphate and glucose-6-phosphate, respectively, into cells (12, 13) . These compounds can be utilized as carbon sources for growth. In addition, EHEC can also use glycerol-3-phosphate as an electron donor for anaerobic respiration, where it is oxidized to dihydroxyacetone phosphate (DHAP) by glycerol-3-phosphate dehydrogenase and transfers electrons to the terminal reductases (33, 34) . Therefore, GlpT and UhpT are closely related to biological fitness for EHEC, and repression of their genes indeed imposes a metabolic burden (17, 18) . Thus, activation of expression of these genes during anaerobic growth may be reasonable from a physiological standpoint for EHEC to reduce the metabolic cost. This concept is also supported by epidemiologic data showing that susceptibility rates have remained relatively stable despite the prevalent use of fosfomycin, though mutants that are resistant to fosfomycin can frequently be isolated from in vitro laboratory cultures (35) (36) (37) (38) (39) . A loss of biological fitness, together with conferred resistance, offers the benefit that the development of resistance to the drug could occur with a low possible incidence even if its use increases in the future. In this study, we also identified the regulatory element that is responsible for activation of glpT and uhpT expression associated with elevated susceptibility to fosfomycin during anaerobic growth. Induction of expression of these genes requires FNR (Fig.  4) . The purified FNR protein bound to the regions upstream of glpT and uhpT; thus, FNR is an activator of these genes (Fig. 5) . We note that the fnr mutant still had some level of uhpT expression; in addition, the affinity of FNR binding to uhpT was relatively lower than that for glpT. This implies that additional regulatory elements may participate in expression of the uhpT gene under anaerobic conditions. Previous studies of the nonpathogenic laboratory E. coli K-12 strain demonstrated that the uhpT gene is activated by UhpA together with cyclic AMP receptor protein (CRP) (40) . UhpA is a response regulator that pairs with UhpB, the sensor kinase, to compose a two-component system, and it is activated in the presence of glucose-6-phosphate (41) . On the other hand, CRP binds cyclic AMP (cAMP), and then the CRP-cAMP complex controls global genes related to bacterial metabolism (42) . Unlike FNR, these transcriptional regulators are able to function under both aerobic and anaerobic conditions. UhpA is essential for expression of uhpT as a specific regulator (43) . CRP-cAMP binds to a region that is relatively remote from the RNA polymerase binding site on the uhpT gene promoter, and then it stabilizes the complex of RNA polymerase, the promoter DNA, and UhpA (40, 44) . In our experiment, UhpA also likely acted as an essential element for expression of uhpT during anaerobic growth in EHEC, because LacZ expression from pNNuhpT-P was below the detectable limit even when cells were grown anaerobically. FNR might act as a cofactor for UhpA as well as CRP-cAMP. Our data will be useful in future studies to complete the picture by adding FNR to the regulatory model for uhpT gene control during anaerobic growth.
We conclude here that the increased antibacterial activity of fosfomycin toward E. coli strains, including EHEC, under anaerobic conditions can be attributed to an elevated expression of GlpT and UhpT that is caused by activation of FNR, which then leads to increased uptake of the drug. We believe that this study will aid us to more precisely understand the utility of this drug in in vivo situations and may provide extensive information to make fosfomycin treatment more effective.
